NPA Board Members Argue Investigating The CEO Was Part Of Their Job
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
NPA's amended complaint includes a purported email trail showing the self-professed "shadow board" plotted to remove CEO Daniel Fabricant. In a motion to dismiss, board members argue that while NPA alleges "a breach of fiduciary duty … they satisfied, rather than violated, their fiduciary duties."
You may also be interested in...
NPA's Former CFO Alleges Improper Expenses By Fabricant, Religious And Gender Harassment
CEO Daniel Fabricant and the NPA board's president say former CFO Brent Weickert's allegations in a complaint filed in California state court are baseless. Weickert, with NPA from 1997 until October, says he was dismissed after he stated his concerns to NPA's board and to Fabricant.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.